Loading…
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company operates hospital services. Founded 23 September 1999.
| Ratio | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 89.9% | 69.1% | 71.3% | 86.3% |
| EBITDA Margin | 56.6% | 6.2% | -10.8% | -5.2% |
| EBITDAR | 1,174 | 81 | -130 | -73 |
| EBITDAR Margin | 56.6% | 6.2% | -10.8% | -5.2% |
| EBIT Margin | 56.1% | 4.2% | -15.5% | -9.0% |
| Net Profit Margin | 56.1% | 4.2% | -17.7% | -10.7% |
| Operating Expense % of Sales | 33.3% | 62.9% | 82.0% | 91.5% |
| Returns | ||||
| Return on Assets (ROA) | 61.3% | 4.1% | -18.0% | -13.0% |
| Return on Equity (ROE) | 70.8% | 5.0% | -23.9% | -20.3% |
| ROIC [EBIT / Invested Capital] | 155.9% | 5.5% | -20.0% | -16.4% |
| Leverage & debt balances | ||||
| Debt-to-Assets | 0.0% | 0.0% | 3.8% | 3.9% |
| Debt-to-Equity | 0.00x | 0.00x | 0.05x | 0.06x |
| Debt-to-EBITDA | 0.00x | 0.01x | N/A | N/A |
| Equity-to-Assets | 86.5% | 83.7% | 75.3% | 64.1% |
| Net Debt | -896 | -107 | 43 | 32 |
| Cash & Equivalents | 896 | 107 | 1 | 14 |
| Total Debt | N/A | 0 | 45 | 45 |
| Liquidity & working capital | ||||
| Current Ratio | 0.17x | 0.57x | 0.13x | 0.07x |
| Quick Ratio | 0.17x | 0.57x | 0.13x | 0.07x |
| Cash Ratio | 19.22x | 5.84x | 0.02x | 0.12x |
| Total Current Assets | 8 | 10 | 10 | 8 |
| Total Current Liabilities | 47 | 18 | 74 | 113 |
| Inventory | N/A | N/A | N/A | N/A |
| Trade Receivables | 493 | 486 | 348 | 316 |
| Trade Payables | 47 | 18 | 29 | 39 |
| Net Working Capital | -39 | -8 | -64 | -105 |
| Net Working Capital % of Revenue | -1.9% | -0.6% | -5.3% | -7.4% |
| Trade Working Capital | 446 | 468 | 319 | 277 |
| Trade Working Capital % of Revenue | 21.5% | 35.9% | 26.4% | 19.7% |
| Change in Trade Working Capital | N/A | 22 | -149 | -42 |
| Turnover & efficiency | ||||
| Inventory Turnover | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A |
| Receivables Turnover | 4.21x | 2.68x | 3.47x | 4.45x |
| Days Sales Outstanding (DSO) | 86.8 | 136.1 | 105.1 | 82.0 |
| Payables Turnover | 4.50x | 22.51x | 11.81x | 4.94x |
| Days Payable Outstanding (DPO) | 81.1 | 16.2 | 30.9 | 73.9 |
| Cash Conversion Cycle | 5.7 days | 119.9 days | 74.2 days | 8.1 days |
| Asset Turnover | 1.09x | 0.98x | 1.02x | 1.21x |
| Cash flow & dividends | ||||
| Operating Cash Flow | 1,865 | 1,211 | 1,400 | 1,424 |
| Free Cash Flow (OCF − Capex proxy) | 1,865 | 1,211 | 1,400 | 1,525 |
| Cash Conversion (OCF / EBITDA) | 158.9% | 1491.3% | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →